Global CD47 IAP Market Research Report 2023(Status and Outlook)
Report Overview
Bosson Research’s latest report provides a deep insight into the global CD47 IAP market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CD47 IAP Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CD47 IAP market in any manner.
Global CD47 IAP Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gilead
Innovent Biologics
Akeso, Inc
Arch Oncology
ImmuneOncia Therapeutics
I-MAB
Sorrento Therapeutics
Zai Lab
ImmuneOnco
Hengrui
Beijing Mab-works
Hanxbio
ALX Oncology
Surface Oncology
TG Therapeutics
EpicentRx
Market Segmentation (by Type)
CD47 Monoclonal Antibody
CD47 Double Antibody
CD47 Fusion Protein
CD47 (IAP)
Market Segmentation (by Application)
Solid Tumor
Lymphoma
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CD47 IAP Market
Overview of the regional outlook of the CD47 IAP Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CD47 IAP Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Bosson Research’s latest report provides a deep insight into the global CD47 IAP market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global CD47 IAP Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the CD47 IAP market in any manner.
Global CD47 IAP Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Gilead
Innovent Biologics
Akeso, Inc
Arch Oncology
ImmuneOncia Therapeutics
I-MAB
Sorrento Therapeutics
Zai Lab
ImmuneOnco
Hengrui
Beijing Mab-works
Hanxbio
ALX Oncology
Surface Oncology
TG Therapeutics
EpicentRx
Market Segmentation (by Type)
CD47 Monoclonal Antibody
CD47 Double Antibody
CD47 Fusion Protein
CD47 (IAP)
Market Segmentation (by Application)
Solid Tumor
Lymphoma
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the CD47 IAP Market
Overview of the regional outlook of the CD47 IAP Market:
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value (USD Billion) data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the CD47 IAP Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of CD47 IAP
1.2 Key Market Segments
1.2.1 CD47 IAP Segment by Type
1.2.2 CD47 IAP Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CD47 IAP MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CD47 IAP Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global CD47 IAP Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CD47 IAP MARKET COMPETITIVE LANDSCAPE
3.1 Global CD47 IAP Sales by Manufacturers (2018-2023)
3.2 Global CD47 IAP Revenue Market Share by Manufacturers (2018-2023)
3.3 CD47 IAP Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CD47 IAP Average Price by Manufacturers (2018-2023)
3.5 Manufacturers CD47 IAP Sales Sites, Area Served, Product Type
3.6 CD47 IAP Market Competitive Situation and Trends
3.6.1 CD47 IAP Market Concentration Rate
3.6.2 Global 5 and 10 Largest CD47 IAP Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CD47 IAP INDUSTRY CHAIN ANALYSIS
4.1 CD47 IAP Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CD47 IAP MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CD47 IAP MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CD47 IAP Sales Market Share by Type (2018-2023)
6.3 Global CD47 IAP Market Size Market Share by Type (2018-2023)
6.4 Global CD47 IAP Price by Type (2018-2023)
7 CD47 IAP MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CD47 IAP Market Sales by Application (2018-2023)
7.3 Global CD47 IAP Market Size (M USD) by Application (2018-2023)
7.4 Global CD47 IAP Sales Growth Rate by Application (2018-2023)
8 CD47 IAP MARKET SEGMENTATION BY REGION
8.1 Global CD47 IAP Sales by Region
8.1.1 Global CD47 IAP Sales by Region
8.1.2 Global CD47 IAP Sales Market Share by Region
8.2 North America
8.2.1 North America CD47 IAP Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CD47 IAP Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CD47 IAP Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CD47 IAP Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CD47 IAP Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Gilead
9.1.1 Gilead CD47 IAP Basic Information
9.1.2 Gilead CD47 IAP Product Overview
9.1.3 Gilead CD47 IAP Product Market Performance
9.1.4 Gilead Business Overview
9.1.5 Gilead CD47 IAP SWOT Analysis
9.1.6 Gilead Recent Developments
9.2 Innovent Biologics
9.2.1 Innovent Biologics CD47 IAP Basic Information
9.2.2 Innovent Biologics CD47 IAP Product Overview
9.2.3 Innovent Biologics CD47 IAP Product Market Performance
9.2.4 Innovent Biologics Business Overview
9.2.5 Innovent Biologics CD47 IAP SWOT Analysis
9.2.6 Innovent Biologics Recent Developments
9.3 Akeso, Inc
9.3.1 Akeso, Inc CD47 IAP Basic Information
9.3.2 Akeso, Inc CD47 IAP Product Overview
9.3.3 Akeso, Inc CD47 IAP Product Market Performance
9.3.4 Akeso, Inc Business Overview
9.3.5 Akeso, Inc CD47 IAP SWOT Analysis
9.3.6 Akeso, Inc Recent Developments
9.4 Arch Oncology
9.4.1 Arch Oncology CD47 IAP Basic Information
9.4.2 Arch Oncology CD47 IAP Product Overview
9.4.3 Arch Oncology CD47 IAP Product Market Performance
9.4.4 Arch Oncology Business Overview
9.4.5 Arch Oncology CD47 IAP SWOT Analysis
9.4.6 Arch Oncology Recent Developments
9.5 ImmuneOncia Therapeutics
9.5.1 ImmuneOncia Therapeutics CD47 IAP Basic Information
9.5.2 ImmuneOncia Therapeutics CD47 IAP Product Overview
9.5.3 ImmuneOncia Therapeutics CD47 IAP Product Market Performance
9.5.4 ImmuneOncia Therapeutics Business Overview
9.5.5 ImmuneOncia Therapeutics CD47 IAP SWOT Analysis
9.5.6 ImmuneOncia Therapeutics Recent Developments
9.6 I-MAB
9.6.1 I-MAB CD47 IAP Basic Information
9.6.2 I-MAB CD47 IAP Product Overview
9.6.3 I-MAB CD47 IAP Product Market Performance
9.6.4 I-MAB Business Overview
9.6.5 I-MAB Recent Developments
9.7 Sorrento Therapeutics
9.7.1 Sorrento Therapeutics CD47 IAP Basic Information
9.7.2 Sorrento Therapeutics CD47 IAP Product Overview
9.7.3 Sorrento Therapeutics CD47 IAP Product Market Performance
9.7.4 Sorrento Therapeutics Business Overview
9.7.5 Sorrento Therapeutics Recent Developments
9.8 Zai Lab
9.8.1 Zai Lab CD47 IAP Basic Information
9.8.2 Zai Lab CD47 IAP Product Overview
9.8.3 Zai Lab CD47 IAP Product Market Performance
9.8.4 Zai Lab Business Overview
9.8.5 Zai Lab Recent Developments
9.9 ImmuneOnco
9.9.1 ImmuneOnco CD47 IAP Basic Information
9.9.2 ImmuneOnco CD47 IAP Product Overview
9.9.3 ImmuneOnco CD47 IAP Product Market Performance
9.9.4 ImmuneOnco Business Overview
9.9.5 ImmuneOnco Recent Developments
9.10 Hengrui
9.10.1 Hengrui CD47 IAP Basic Information
9.10.2 Hengrui CD47 IAP Product Overview
9.10.3 Hengrui CD47 IAP Product Market Performance
9.10.4 Hengrui Business Overview
9.10.5 Hengrui Recent Developments
9.11 Beijing Mab-works
9.11.1 Beijing Mab-works CD47 IAP Basic Information
9.11.2 Beijing Mab-works CD47 IAP Product Overview
9.11.3 Beijing Mab-works CD47 IAP Product Market Performance
9.11.4 Beijing Mab-works Business Overview
9.11.5 Beijing Mab-works Recent Developments
9.12 Hanxbio
9.12.1 Hanxbio CD47 IAP Basic Information
9.12.2 Hanxbio CD47 IAP Product Overview
9.12.3 Hanxbio CD47 IAP Product Market Performance
9.12.4 Hanxbio Business Overview
9.12.5 Hanxbio Recent Developments
9.13 ALX Oncology
9.13.1 ALX Oncology CD47 IAP Basic Information
9.13.2 ALX Oncology CD47 IAP Product Overview
9.13.3 ALX Oncology CD47 IAP Product Market Performance
9.13.4 ALX Oncology Business Overview
9.13.5 ALX Oncology Recent Developments
9.14 Surface Oncology
9.14.1 Surface Oncology CD47 IAP Basic Information
9.14.2 Surface Oncology CD47 IAP Product Overview
9.14.3 Surface Oncology CD47 IAP Product Market Performance
9.14.4 Surface Oncology Business Overview
9.14.5 Surface Oncology Recent Developments
9.15 TG Therapeutics
9.15.1 TG Therapeutics CD47 IAP Basic Information
9.15.2 TG Therapeutics CD47 IAP Product Overview
9.15.3 TG Therapeutics CD47 IAP Product Market Performance
9.15.4 TG Therapeutics Business Overview
9.15.5 TG Therapeutics Recent Developments
9.16 EpicentRx
9.16.1 EpicentRx CD47 IAP Basic Information
9.16.2 EpicentRx CD47 IAP Product Overview
9.16.3 EpicentRx CD47 IAP Product Market Performance
9.16.4 EpicentRx Business Overview
9.16.5 EpicentRx Recent Developments
10 CD47 IAP MARKET FORECAST BY REGION
10.1 Global CD47 IAP Market Size Forecast
10.2 Global CD47 IAP Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CD47 IAP Market Size Forecast by Country
10.2.3 Asia Pacific CD47 IAP Market Size Forecast by Region
10.2.4 South America CD47 IAP Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CD47 IAP by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global CD47 IAP Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of CD47 IAP by Type (2024-2029)
11.1.2 Global CD47 IAP Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of CD47 IAP by Type (2024-2029)
11.2 Global CD47 IAP Market Forecast by Application (2024-2029)
11.2.1 Global CD47 IAP Sales (K MT) Forecast by Application
11.2.2 Global CD47 IAP Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of CD47 IAP
1.2 Key Market Segments
1.2.1 CD47 IAP Segment by Type
1.2.2 CD47 IAP Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 CD47 IAP MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global CD47 IAP Market Size (M USD) Estimates and Forecasts (2018-2029)
2.1.2 Global CD47 IAP Sales Estimates and Forecasts (2018-2029)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 CD47 IAP MARKET COMPETITIVE LANDSCAPE
3.1 Global CD47 IAP Sales by Manufacturers (2018-2023)
3.2 Global CD47 IAP Revenue Market Share by Manufacturers (2018-2023)
3.3 CD47 IAP Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global CD47 IAP Average Price by Manufacturers (2018-2023)
3.5 Manufacturers CD47 IAP Sales Sites, Area Served, Product Type
3.6 CD47 IAP Market Competitive Situation and Trends
3.6.1 CD47 IAP Market Concentration Rate
3.6.2 Global 5 and 10 Largest CD47 IAP Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 CD47 IAP INDUSTRY CHAIN ANALYSIS
4.1 CD47 IAP Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF CD47 IAP MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 CD47 IAP MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global CD47 IAP Sales Market Share by Type (2018-2023)
6.3 Global CD47 IAP Market Size Market Share by Type (2018-2023)
6.4 Global CD47 IAP Price by Type (2018-2023)
7 CD47 IAP MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global CD47 IAP Market Sales by Application (2018-2023)
7.3 Global CD47 IAP Market Size (M USD) by Application (2018-2023)
7.4 Global CD47 IAP Sales Growth Rate by Application (2018-2023)
8 CD47 IAP MARKET SEGMENTATION BY REGION
8.1 Global CD47 IAP Sales by Region
8.1.1 Global CD47 IAP Sales by Region
8.1.2 Global CD47 IAP Sales Market Share by Region
8.2 North America
8.2.1 North America CD47 IAP Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe CD47 IAP Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific CD47 IAP Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America CD47 IAP Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa CD47 IAP Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Gilead
9.1.1 Gilead CD47 IAP Basic Information
9.1.2 Gilead CD47 IAP Product Overview
9.1.3 Gilead CD47 IAP Product Market Performance
9.1.4 Gilead Business Overview
9.1.5 Gilead CD47 IAP SWOT Analysis
9.1.6 Gilead Recent Developments
9.2 Innovent Biologics
9.2.1 Innovent Biologics CD47 IAP Basic Information
9.2.2 Innovent Biologics CD47 IAP Product Overview
9.2.3 Innovent Biologics CD47 IAP Product Market Performance
9.2.4 Innovent Biologics Business Overview
9.2.5 Innovent Biologics CD47 IAP SWOT Analysis
9.2.6 Innovent Biologics Recent Developments
9.3 Akeso, Inc
9.3.1 Akeso, Inc CD47 IAP Basic Information
9.3.2 Akeso, Inc CD47 IAP Product Overview
9.3.3 Akeso, Inc CD47 IAP Product Market Performance
9.3.4 Akeso, Inc Business Overview
9.3.5 Akeso, Inc CD47 IAP SWOT Analysis
9.3.6 Akeso, Inc Recent Developments
9.4 Arch Oncology
9.4.1 Arch Oncology CD47 IAP Basic Information
9.4.2 Arch Oncology CD47 IAP Product Overview
9.4.3 Arch Oncology CD47 IAP Product Market Performance
9.4.4 Arch Oncology Business Overview
9.4.5 Arch Oncology CD47 IAP SWOT Analysis
9.4.6 Arch Oncology Recent Developments
9.5 ImmuneOncia Therapeutics
9.5.1 ImmuneOncia Therapeutics CD47 IAP Basic Information
9.5.2 ImmuneOncia Therapeutics CD47 IAP Product Overview
9.5.3 ImmuneOncia Therapeutics CD47 IAP Product Market Performance
9.5.4 ImmuneOncia Therapeutics Business Overview
9.5.5 ImmuneOncia Therapeutics CD47 IAP SWOT Analysis
9.5.6 ImmuneOncia Therapeutics Recent Developments
9.6 I-MAB
9.6.1 I-MAB CD47 IAP Basic Information
9.6.2 I-MAB CD47 IAP Product Overview
9.6.3 I-MAB CD47 IAP Product Market Performance
9.6.4 I-MAB Business Overview
9.6.5 I-MAB Recent Developments
9.7 Sorrento Therapeutics
9.7.1 Sorrento Therapeutics CD47 IAP Basic Information
9.7.2 Sorrento Therapeutics CD47 IAP Product Overview
9.7.3 Sorrento Therapeutics CD47 IAP Product Market Performance
9.7.4 Sorrento Therapeutics Business Overview
9.7.5 Sorrento Therapeutics Recent Developments
9.8 Zai Lab
9.8.1 Zai Lab CD47 IAP Basic Information
9.8.2 Zai Lab CD47 IAP Product Overview
9.8.3 Zai Lab CD47 IAP Product Market Performance
9.8.4 Zai Lab Business Overview
9.8.5 Zai Lab Recent Developments
9.9 ImmuneOnco
9.9.1 ImmuneOnco CD47 IAP Basic Information
9.9.2 ImmuneOnco CD47 IAP Product Overview
9.9.3 ImmuneOnco CD47 IAP Product Market Performance
9.9.4 ImmuneOnco Business Overview
9.9.5 ImmuneOnco Recent Developments
9.10 Hengrui
9.10.1 Hengrui CD47 IAP Basic Information
9.10.2 Hengrui CD47 IAP Product Overview
9.10.3 Hengrui CD47 IAP Product Market Performance
9.10.4 Hengrui Business Overview
9.10.5 Hengrui Recent Developments
9.11 Beijing Mab-works
9.11.1 Beijing Mab-works CD47 IAP Basic Information
9.11.2 Beijing Mab-works CD47 IAP Product Overview
9.11.3 Beijing Mab-works CD47 IAP Product Market Performance
9.11.4 Beijing Mab-works Business Overview
9.11.5 Beijing Mab-works Recent Developments
9.12 Hanxbio
9.12.1 Hanxbio CD47 IAP Basic Information
9.12.2 Hanxbio CD47 IAP Product Overview
9.12.3 Hanxbio CD47 IAP Product Market Performance
9.12.4 Hanxbio Business Overview
9.12.5 Hanxbio Recent Developments
9.13 ALX Oncology
9.13.1 ALX Oncology CD47 IAP Basic Information
9.13.2 ALX Oncology CD47 IAP Product Overview
9.13.3 ALX Oncology CD47 IAP Product Market Performance
9.13.4 ALX Oncology Business Overview
9.13.5 ALX Oncology Recent Developments
9.14 Surface Oncology
9.14.1 Surface Oncology CD47 IAP Basic Information
9.14.2 Surface Oncology CD47 IAP Product Overview
9.14.3 Surface Oncology CD47 IAP Product Market Performance
9.14.4 Surface Oncology Business Overview
9.14.5 Surface Oncology Recent Developments
9.15 TG Therapeutics
9.15.1 TG Therapeutics CD47 IAP Basic Information
9.15.2 TG Therapeutics CD47 IAP Product Overview
9.15.3 TG Therapeutics CD47 IAP Product Market Performance
9.15.4 TG Therapeutics Business Overview
9.15.5 TG Therapeutics Recent Developments
9.16 EpicentRx
9.16.1 EpicentRx CD47 IAP Basic Information
9.16.2 EpicentRx CD47 IAP Product Overview
9.16.3 EpicentRx CD47 IAP Product Market Performance
9.16.4 EpicentRx Business Overview
9.16.5 EpicentRx Recent Developments
10 CD47 IAP MARKET FORECAST BY REGION
10.1 Global CD47 IAP Market Size Forecast
10.2 Global CD47 IAP Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe CD47 IAP Market Size Forecast by Country
10.2.3 Asia Pacific CD47 IAP Market Size Forecast by Region
10.2.4 South America CD47 IAP Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of CD47 IAP by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2024-2029)
11.1 Global CD47 IAP Market Forecast by Type (2024-2029)
11.1.1 Global Forecasted Sales of CD47 IAP by Type (2024-2029)
11.1.2 Global CD47 IAP Market Size Forecast by Type (2024-2029)
11.1.3 Global Forecasted Price of CD47 IAP by Type (2024-2029)
11.2 Global CD47 IAP Market Forecast by Application (2024-2029)
11.2.1 Global CD47 IAP Sales (K MT) Forecast by Application
11.2.2 Global CD47 IAP Market Size (M USD) Forecast by Application (2024-2029)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CD47 IAP Market Size Comparison by Region (M USD)
Table 5. Global CD47 IAP Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global CD47 IAP Sales Market Share by Manufacturers (2018-2023)
Table 7. Global CD47 IAP Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global CD47 IAP Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD47 IAP as of 2022)
Table 10. Global Market CD47 IAP Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers CD47 IAP Sales Sites and Area Served
Table 12. Manufacturers CD47 IAP Product Type
Table 13. Global CD47 IAP Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CD47 IAP
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CD47 IAP Market Challenges
Table 22. Market Restraints
Table 23. Global CD47 IAP Sales by Type (K MT)
Table 24. Global CD47 IAP Market Size by Type (M USD)
Table 25. Global CD47 IAP Sales (K MT) by Type (2018-2023)
Table 26. Global CD47 IAP Sales Market Share by Type (2018-2023)
Table 27. Global CD47 IAP Market Size (M USD) by Type (2018-2023)
Table 28. Global CD47 IAP Market Size Share by Type (2018-2023)
Table 29. Global CD47 IAP Price (USD/MT) by Type (2018-2023)
Table 30. Global CD47 IAP Sales (K MT) by Application
Table 31. Global CD47 IAP Market Size by Application
Table 32. Global CD47 IAP Sales by Application (2018-2023) & (K MT)
Table 33. Global CD47 IAP Sales Market Share by Application (2018-2023)
Table 34. Global CD47 IAP Sales by Application (2018-2023) & (M USD)
Table 35. Global CD47 IAP Market Share by Application (2018-2023)
Table 36. Global CD47 IAP Sales Growth Rate by Application (2018-2023)
Table 37. Global CD47 IAP Sales by Region (2018-2023) & (K MT)
Table 38. Global CD47 IAP Sales Market Share by Region (2018-2023)
Table 39. North America CD47 IAP Sales by Country (2018-2023) & (K MT)
Table 40. Europe CD47 IAP Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific CD47 IAP Sales by Region (2018-2023) & (K MT)
Table 42. South America CD47 IAP Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa CD47 IAP Sales by Region (2018-2023) & (K MT)
Table 44. Gilead CD47 IAP Basic Information
Table 45. Gilead CD47 IAP Product Overview
Table 46. Gilead CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Gilead Business Overview
Table 48. Gilead CD47 IAP SWOT Analysis
Table 49. Gilead Recent Developments
Table 50. Innovent Biologics CD47 IAP Basic Information
Table 51. Innovent Biologics CD47 IAP Product Overview
Table 52. Innovent Biologics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Innovent Biologics Business Overview
Table 54. Innovent Biologics CD47 IAP SWOT Analysis
Table 55. Innovent Biologics Recent Developments
Table 56. Akeso, Inc CD47 IAP Basic Information
Table 57. Akeso, Inc CD47 IAP Product Overview
Table 58. Akeso, Inc CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Akeso, Inc Business Overview
Table 60. Akeso, Inc CD47 IAP SWOT Analysis
Table 61. Akeso, Inc Recent Developments
Table 62. Arch Oncology CD47 IAP Basic Information
Table 63. Arch Oncology CD47 IAP Product Overview
Table 64. Arch Oncology CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Arch Oncology Business Overview
Table 66. Arch Oncology CD47 IAP SWOT Analysis
Table 67. Arch Oncology Recent Developments
Table 68. ImmuneOncia Therapeutics CD47 IAP Basic Information
Table 69. ImmuneOncia Therapeutics CD47 IAP Product Overview
Table 70. ImmuneOncia Therapeutics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. ImmuneOncia Therapeutics Business Overview
Table 72. ImmuneOncia Therapeutics CD47 IAP SWOT Analysis
Table 73. ImmuneOncia Therapeutics Recent Developments
Table 74. I-MAB CD47 IAP Basic Information
Table 75. I-MAB CD47 IAP Product Overview
Table 76. I-MAB CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. I-MAB Business Overview
Table 78. I-MAB Recent Developments
Table 79. Sorrento Therapeutics CD47 IAP Basic Information
Table 80. Sorrento Therapeutics CD47 IAP Product Overview
Table 81. Sorrento Therapeutics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Sorrento Therapeutics Business Overview
Table 83. Sorrento Therapeutics Recent Developments
Table 84. Zai Lab CD47 IAP Basic Information
Table 85. Zai Lab CD47 IAP Product Overview
Table 86. Zai Lab CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Zai Lab Business Overview
Table 88. Zai Lab Recent Developments
Table 89. ImmuneOnco CD47 IAP Basic Information
Table 90. ImmuneOnco CD47 IAP Product Overview
Table 91. ImmuneOnco CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. ImmuneOnco Business Overview
Table 93. ImmuneOnco Recent Developments
Table 94. Hengrui CD47 IAP Basic Information
Table 95. Hengrui CD47 IAP Product Overview
Table 96. Hengrui CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Hengrui Business Overview
Table 98. Hengrui Recent Developments
Table 99. Beijing Mab-works CD47 IAP Basic Information
Table 100. Beijing Mab-works CD47 IAP Product Overview
Table 101. Beijing Mab-works CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Beijing Mab-works Business Overview
Table 103. Beijing Mab-works Recent Developments
Table 104. Hanxbio CD47 IAP Basic Information
Table 105. Hanxbio CD47 IAP Product Overview
Table 106. Hanxbio CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Hanxbio Business Overview
Table 108. Hanxbio Recent Developments
Table 109. ALX Oncology CD47 IAP Basic Information
Table 110. ALX Oncology CD47 IAP Product Overview
Table 111. ALX Oncology CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. ALX Oncology Business Overview
Table 113. ALX Oncology Recent Developments
Table 114. Surface Oncology CD47 IAP Basic Information
Table 115. Surface Oncology CD47 IAP Product Overview
Table 116. Surface Oncology CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Surface Oncology Business Overview
Table 118. Surface Oncology Recent Developments
Table 119. TG Therapeutics CD47 IAP Basic Information
Table 120. TG Therapeutics CD47 IAP Product Overview
Table 121. TG Therapeutics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. TG Therapeutics Business Overview
Table 123. TG Therapeutics Recent Developments
Table 124. EpicentRx CD47 IAP Basic Information
Table 125. EpicentRx CD47 IAP Product Overview
Table 126. EpicentRx CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. EpicentRx Business Overview
Table 128. EpicentRx Recent Developments
Table 129. Global CD47 IAP Sales Forecast by Region (2024-2029) & (K MT)
Table 130. Global CD47 IAP Market Size Forecast by Region (2024-2029) & (M USD)
Table 131. North America CD47 IAP Sales Forecast by Country (2024-2029) & (K MT)
Table 132. North America CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 133. Europe CD47 IAP Sales Forecast by Country (2024-2029) & (K MT)
Table 134. Europe CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 135. Asia Pacific CD47 IAP Sales Forecast by Region (2024-2029) & (K MT)
Table 136. Asia Pacific CD47 IAP Market Size Forecast by Region (2024-2029) & (M USD)
Table 137. South America CD47 IAP Sales Forecast by Country (2024-2029) & (K MT)
Table 138. South America CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 139. Middle East and Africa CD47 IAP Consumption Forecast by Country (2024-2029) & (Units)
Table 140. Middle East and Africa CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 141. Global CD47 IAP Sales Forecast by Type (2024-2029) & (K MT)
Table 142. Global CD47 IAP Market Size Forecast by Type (2024-2029) & (M USD)
Table 143. Global CD47 IAP Price Forecast by Type (2024-2029) & (USD/MT)
Table 144. Global CD47 IAP Sales (K MT) Forecast by Application (2024-2029)
Table 145. Global CD47 IAP Market Size Forecast by Application (2024-2029) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. CD47 IAP Market Size Comparison by Region (M USD)
Table 5. Global CD47 IAP Sales (K MT) by Manufacturers (2018-2023)
Table 6. Global CD47 IAP Sales Market Share by Manufacturers (2018-2023)
Table 7. Global CD47 IAP Revenue (M USD) by Manufacturers (2018-2023)
Table 8. Global CD47 IAP Revenue Share by Manufacturers (2018-2023)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CD47 IAP as of 2022)
Table 10. Global Market CD47 IAP Average Price (USD/MT) of Key Manufacturers (2018-2023)
Table 11. Manufacturers CD47 IAP Sales Sites and Area Served
Table 12. Manufacturers CD47 IAP Product Type
Table 13. Global CD47 IAP Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of CD47 IAP
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. CD47 IAP Market Challenges
Table 22. Market Restraints
Table 23. Global CD47 IAP Sales by Type (K MT)
Table 24. Global CD47 IAP Market Size by Type (M USD)
Table 25. Global CD47 IAP Sales (K MT) by Type (2018-2023)
Table 26. Global CD47 IAP Sales Market Share by Type (2018-2023)
Table 27. Global CD47 IAP Market Size (M USD) by Type (2018-2023)
Table 28. Global CD47 IAP Market Size Share by Type (2018-2023)
Table 29. Global CD47 IAP Price (USD/MT) by Type (2018-2023)
Table 30. Global CD47 IAP Sales (K MT) by Application
Table 31. Global CD47 IAP Market Size by Application
Table 32. Global CD47 IAP Sales by Application (2018-2023) & (K MT)
Table 33. Global CD47 IAP Sales Market Share by Application (2018-2023)
Table 34. Global CD47 IAP Sales by Application (2018-2023) & (M USD)
Table 35. Global CD47 IAP Market Share by Application (2018-2023)
Table 36. Global CD47 IAP Sales Growth Rate by Application (2018-2023)
Table 37. Global CD47 IAP Sales by Region (2018-2023) & (K MT)
Table 38. Global CD47 IAP Sales Market Share by Region (2018-2023)
Table 39. North America CD47 IAP Sales by Country (2018-2023) & (K MT)
Table 40. Europe CD47 IAP Sales by Country (2018-2023) & (K MT)
Table 41. Asia Pacific CD47 IAP Sales by Region (2018-2023) & (K MT)
Table 42. South America CD47 IAP Sales by Country (2018-2023) & (K MT)
Table 43. Middle East and Africa CD47 IAP Sales by Region (2018-2023) & (K MT)
Table 44. Gilead CD47 IAP Basic Information
Table 45. Gilead CD47 IAP Product Overview
Table 46. Gilead CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 47. Gilead Business Overview
Table 48. Gilead CD47 IAP SWOT Analysis
Table 49. Gilead Recent Developments
Table 50. Innovent Biologics CD47 IAP Basic Information
Table 51. Innovent Biologics CD47 IAP Product Overview
Table 52. Innovent Biologics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 53. Innovent Biologics Business Overview
Table 54. Innovent Biologics CD47 IAP SWOT Analysis
Table 55. Innovent Biologics Recent Developments
Table 56. Akeso, Inc CD47 IAP Basic Information
Table 57. Akeso, Inc CD47 IAP Product Overview
Table 58. Akeso, Inc CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 59. Akeso, Inc Business Overview
Table 60. Akeso, Inc CD47 IAP SWOT Analysis
Table 61. Akeso, Inc Recent Developments
Table 62. Arch Oncology CD47 IAP Basic Information
Table 63. Arch Oncology CD47 IAP Product Overview
Table 64. Arch Oncology CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 65. Arch Oncology Business Overview
Table 66. Arch Oncology CD47 IAP SWOT Analysis
Table 67. Arch Oncology Recent Developments
Table 68. ImmuneOncia Therapeutics CD47 IAP Basic Information
Table 69. ImmuneOncia Therapeutics CD47 IAP Product Overview
Table 70. ImmuneOncia Therapeutics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 71. ImmuneOncia Therapeutics Business Overview
Table 72. ImmuneOncia Therapeutics CD47 IAP SWOT Analysis
Table 73. ImmuneOncia Therapeutics Recent Developments
Table 74. I-MAB CD47 IAP Basic Information
Table 75. I-MAB CD47 IAP Product Overview
Table 76. I-MAB CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 77. I-MAB Business Overview
Table 78. I-MAB Recent Developments
Table 79. Sorrento Therapeutics CD47 IAP Basic Information
Table 80. Sorrento Therapeutics CD47 IAP Product Overview
Table 81. Sorrento Therapeutics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 82. Sorrento Therapeutics Business Overview
Table 83. Sorrento Therapeutics Recent Developments
Table 84. Zai Lab CD47 IAP Basic Information
Table 85. Zai Lab CD47 IAP Product Overview
Table 86. Zai Lab CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 87. Zai Lab Business Overview
Table 88. Zai Lab Recent Developments
Table 89. ImmuneOnco CD47 IAP Basic Information
Table 90. ImmuneOnco CD47 IAP Product Overview
Table 91. ImmuneOnco CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 92. ImmuneOnco Business Overview
Table 93. ImmuneOnco Recent Developments
Table 94. Hengrui CD47 IAP Basic Information
Table 95. Hengrui CD47 IAP Product Overview
Table 96. Hengrui CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 97. Hengrui Business Overview
Table 98. Hengrui Recent Developments
Table 99. Beijing Mab-works CD47 IAP Basic Information
Table 100. Beijing Mab-works CD47 IAP Product Overview
Table 101. Beijing Mab-works CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 102. Beijing Mab-works Business Overview
Table 103. Beijing Mab-works Recent Developments
Table 104. Hanxbio CD47 IAP Basic Information
Table 105. Hanxbio CD47 IAP Product Overview
Table 106. Hanxbio CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 107. Hanxbio Business Overview
Table 108. Hanxbio Recent Developments
Table 109. ALX Oncology CD47 IAP Basic Information
Table 110. ALX Oncology CD47 IAP Product Overview
Table 111. ALX Oncology CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 112. ALX Oncology Business Overview
Table 113. ALX Oncology Recent Developments
Table 114. Surface Oncology CD47 IAP Basic Information
Table 115. Surface Oncology CD47 IAP Product Overview
Table 116. Surface Oncology CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 117. Surface Oncology Business Overview
Table 118. Surface Oncology Recent Developments
Table 119. TG Therapeutics CD47 IAP Basic Information
Table 120. TG Therapeutics CD47 IAP Product Overview
Table 121. TG Therapeutics CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 122. TG Therapeutics Business Overview
Table 123. TG Therapeutics Recent Developments
Table 124. EpicentRx CD47 IAP Basic Information
Table 125. EpicentRx CD47 IAP Product Overview
Table 126. EpicentRx CD47 IAP Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2018-2023)
Table 127. EpicentRx Business Overview
Table 128. EpicentRx Recent Developments
Table 129. Global CD47 IAP Sales Forecast by Region (2024-2029) & (K MT)
Table 130. Global CD47 IAP Market Size Forecast by Region (2024-2029) & (M USD)
Table 131. North America CD47 IAP Sales Forecast by Country (2024-2029) & (K MT)
Table 132. North America CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 133. Europe CD47 IAP Sales Forecast by Country (2024-2029) & (K MT)
Table 134. Europe CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 135. Asia Pacific CD47 IAP Sales Forecast by Region (2024-2029) & (K MT)
Table 136. Asia Pacific CD47 IAP Market Size Forecast by Region (2024-2029) & (M USD)
Table 137. South America CD47 IAP Sales Forecast by Country (2024-2029) & (K MT)
Table 138. South America CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 139. Middle East and Africa CD47 IAP Consumption Forecast by Country (2024-2029) & (Units)
Table 140. Middle East and Africa CD47 IAP Market Size Forecast by Country (2024-2029) & (M USD)
Table 141. Global CD47 IAP Sales Forecast by Type (2024-2029) & (K MT)
Table 142. Global CD47 IAP Market Size Forecast by Type (2024-2029) & (M USD)
Table 143. Global CD47 IAP Price Forecast by Type (2024-2029) & (USD/MT)
Table 144. Global CD47 IAP Sales (K MT) Forecast by Application (2024-2029)
Table 145. Global CD47 IAP Market Size Forecast by Application (2024-2029) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of CD47 IAP
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CD47 IAP Market Size (M USD), 2018-2029
Figure 5. Global CD47 IAP Market Size (M USD) (2018-2029)
Figure 6. Global CD47 IAP Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CD47 IAP Market Size by Country (M USD)
Figure 11. CD47 IAP Sales Share by Manufacturers in 2022
Figure 12. Global CD47 IAP Revenue Share by Manufacturers in 2022
Figure 13. CD47 IAP Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market CD47 IAP Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by CD47 IAP Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CD47 IAP Market Share by Type
Figure 18. Sales Market Share of CD47 IAP by Type (2018-2023)
Figure 19. Sales Market Share of CD47 IAP by Type in 2022
Figure 20. Market Size Share of CD47 IAP by Type (2018-2023)
Figure 21. Market Size Market Share of CD47 IAP by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CD47 IAP Market Share by Application
Figure 24. Global CD47 IAP Sales Market Share by Application (2018-2023)
Figure 25. Global CD47 IAP Sales Market Share by Application in 2022
Figure 26. Global CD47 IAP Market Share by Application (2018-2023)
Figure 27. Global CD47 IAP Market Share by Application in 2022
Figure 28. Global CD47 IAP Sales Growth Rate by Application (2018-2023)
Figure 29. Global CD47 IAP Sales Market Share by Region (2018-2023)
Figure 30. North America CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America CD47 IAP Sales Market Share by Country in 2022
Figure 32. U.S. CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada CD47 IAP Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico CD47 IAP Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe CD47 IAP Sales Market Share by Country in 2022
Figure 37. Germany CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific CD47 IAP Sales and Growth Rate (K MT)
Figure 43. Asia Pacific CD47 IAP Sales Market Share by Region in 2022
Figure 44. China CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America CD47 IAP Sales and Growth Rate (K MT)
Figure 50. South America CD47 IAP Sales Market Share by Country in 2022
Figure 51. Brazil CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa CD47 IAP Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa CD47 IAP Sales Market Share by Region in 2022
Figure 56. Saudi Arabia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global CD47 IAP Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global CD47 IAP Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global CD47 IAP Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global CD47 IAP Market Share Forecast by Type (2024-2029)
Figure 65. Global CD47 IAP Sales Forecast by Application (2024-2029)
Figure 66. Global CD47 IAP Market Share Forecast by Application (2024-2029)
Figure 1. Product Picture of CD47 IAP
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global CD47 IAP Market Size (M USD), 2018-2029
Figure 5. Global CD47 IAP Market Size (M USD) (2018-2029)
Figure 6. Global CD47 IAP Sales (K MT) & (2018-2029)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. CD47 IAP Market Size by Country (M USD)
Figure 11. CD47 IAP Sales Share by Manufacturers in 2022
Figure 12. Global CD47 IAP Revenue Share by Manufacturers in 2022
Figure 13. CD47 IAP Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 Vs 2022
Figure 14. Global Market CD47 IAP Average Price (USD/MT) of Key Manufacturers in 2022
Figure 15. The Global 5 and 10 Largest Players: Market Share by CD47 IAP Revenue in 2022
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global CD47 IAP Market Share by Type
Figure 18. Sales Market Share of CD47 IAP by Type (2018-2023)
Figure 19. Sales Market Share of CD47 IAP by Type in 2022
Figure 20. Market Size Share of CD47 IAP by Type (2018-2023)
Figure 21. Market Size Market Share of CD47 IAP by Type in 2022
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global CD47 IAP Market Share by Application
Figure 24. Global CD47 IAP Sales Market Share by Application (2018-2023)
Figure 25. Global CD47 IAP Sales Market Share by Application in 2022
Figure 26. Global CD47 IAP Market Share by Application (2018-2023)
Figure 27. Global CD47 IAP Market Share by Application in 2022
Figure 28. Global CD47 IAP Sales Growth Rate by Application (2018-2023)
Figure 29. Global CD47 IAP Sales Market Share by Region (2018-2023)
Figure 30. North America CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 31. North America CD47 IAP Sales Market Share by Country in 2022
Figure 32. U.S. CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 33. Canada CD47 IAP Sales (K MT) and Growth Rate (2018-2023)
Figure 34. Mexico CD47 IAP Sales (Units) and Growth Rate (2018-2023)
Figure 35. Europe CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 36. Europe CD47 IAP Sales Market Share by Country in 2022
Figure 37. Germany CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 38. France CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 39. U.K. CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 40. Italy CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 41. Russia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 42. Asia Pacific CD47 IAP Sales and Growth Rate (K MT)
Figure 43. Asia Pacific CD47 IAP Sales Market Share by Region in 2022
Figure 44. China CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 45. Japan CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 46. South Korea CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 47. India CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 48. Southeast Asia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 49. South America CD47 IAP Sales and Growth Rate (K MT)
Figure 50. South America CD47 IAP Sales Market Share by Country in 2022
Figure 51. Brazil CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 52. Argentina CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 53. Columbia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 54. Middle East and Africa CD47 IAP Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa CD47 IAP Sales Market Share by Region in 2022
Figure 56. Saudi Arabia CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 57. UAE CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 58. Egypt CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 59. Nigeria CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 60. South Africa CD47 IAP Sales and Growth Rate (2018-2023) & (K MT)
Figure 61. Global CD47 IAP Sales Forecast by Volume (2018-2029) & (K MT)
Figure 62. Global CD47 IAP Market Size Forecast by Value (2018-2029) & (M USD)
Figure 63. Global CD47 IAP Sales Market Share Forecast by Type (2024-2029)
Figure 64. Global CD47 IAP Market Share Forecast by Type (2024-2029)
Figure 65. Global CD47 IAP Sales Forecast by Application (2024-2029)
Figure 66. Global CD47 IAP Market Share Forecast by Application (2024-2029)
